2nd World Immunotherapy Council Young Investigators Symposium

November 8, 2017 • 1-7 p.m.

WIC_1.jpg
WIC_2.jpg
WIC_3.jpg

Program Purpose

The Society for Immunotherapy of Cancer (SITC) and the World Immunotherapy Council (WIC) are dedicated to advancing cancer immunotherapy and, likewise, the future leaders of the field. This program will provide the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.

The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, will contribute insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment. This program and its participants will ultimately highlight worldwide initiatives in cancer immunotherapy and facilitate scientific exchange and networking between today’s and tomorrow’s leaders. Additionally, this forum will provide a unique opportunity to showcase the world’s young, talented scientists and provide an opportunity for knowledge exchange and networking for these selected representatives. 

Intended Audience

The target audience for this program consists of individuals from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals who wish to learn more about the future of cancer immunotherapy research across the globe.

Educational Objectives

Upon completion of this program, the participants will be able to:

  • Recognize ongoing cancer immunotherapy research across the globe
  • Translate worldwide state-of-the-art cancer immunotherapy strategies into practice
  • Identify the unique challenges and future issues as cancer immunotherapy is integrated into mainstream cancer treatment modalities.

 

Americans with Disabilities Act

handicap.pngEvent staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.). Please contact SITC prior to the live event at +1 414-271-2456.

Program Organizers

This program is organized in collaboration with the World Immunotherapy Council. The following individuals are recognized for their leadership in developing this program:

  • Tanja D. De Gruijl, PhDVU University Medical Center
  • Brad Nelson, PhDBC Cancer Agency, Deeley Research Centre
  • Graham P. Pawelec, PhDUniversity of Tuebingen
SITC's 2nd World Immunotherapy Council Young Investigator Symposium is supported in part by grants from AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb and Pfizer, Inc.